Trastuzumab (anti-HER2), CAS 180288-69-1

Product Description: Trastuzumab (PBS) is a humanized IgG1 monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab (PBS) has the potential for HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer research.

Applications: Cancer-Kinase/protease

Formula: N/A

References: [1]Sliwkowski MX, et al. Nonclinical studies addressing the mechanism of action of trastuzumab. Semin Oncol. 1999 Aug;26(4 Suppl 12):60-70./[2]Hudis CA, et al. Trastuzumab--mechanism of action and use in clinical practice. N Engl J Med. 2007 Jul 5;357(1):39-51./[3]Barok M, et al. Trastuzumab causes antibody-dependent cellular cytotoxicity-mediated growth inhibition of submacroscopic JIMT-1 breast cancer xenografts despite intrinsic drug resistance. Mol Cancer Ther. 2007 Jul;6(7):2065-72.

CAS Number: 180288-69-1

Molecular Weight: N/A

Compound Purity: 99.62

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: ADC Antibody;EGFR

• Artikelnummer: MEXHY-P9907A-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P9907A-1
• Green Labware: Nein
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK